 | • レポートコード：QFJ1-5128 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、結腸直腸癌診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（FOB検査、CTC検査、CEA検査、その他）、用途別市場規模（病院、専門クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・結腸直腸癌診断の市場動向 ・企業の競争状況、市場シェア ・結腸直腸癌診断の種類別市場規模と予測2016-2027（FOB検査、CTC検査、CEA検査、その他） ・結腸直腸癌診断の用途別市場規模と予測2016-2027（病院、専門クリニック、その他） ・結腸直腸癌診断の北米市場規模2016-2027（アメリカ、カナダ） ・結腸直腸癌診断の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・結腸直腸癌診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・結腸直腸癌診断の中南米市場規模2016-2027（メキシコ、ブラジル） ・結腸直腸癌診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Biocept、Cancer Genetics、Foundation Medicine、Sysmex Corporation、Danaher Corporation、Epigenomics、Illumina、Rosetta Genomics、Exact Science Corporation、Pathway Genomics Corporation） ・結論 |
Colorectal cancer diagnostics are a wide range of screening tests and diagnosis procedures that are employed before treating a patient with colon cancer. A typical diagnosis of colorectal cancer consists of tests such as colonoscopy, biopsy, blood sample testing, CT scan, ultrasound, MRI and molecular testing of the growing tumor.
Market Analysis and Insights: Global Colorectal Cancer Diagnostics Market
The global Colorectal Cancer Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Colorectal Cancer Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Colorectal Cancer Diagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Colorectal Cancer Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Colorectal Cancer Diagnostics market.
Global Colorectal Cancer Diagnostics Scope and Market Size
Colorectal Cancer Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Colorectal Cancer Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
FOB Tests
CTC Tests
CEA Tests
Others
Segment by Application
Hospitals
Specialty Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Biocept
Cancer Genetics
Foundation Medicine
Sysmex Corporation
Danaher Corporation
Epigenomics
Illumina
Rosetta Genomics
Exact Science Corporation
Pathway Genomics Corporation
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Colorectal Cancer Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 FOB Tests
1.2.3 CTC Tests
1.2.4 CEA Tests
1.2.5 Others
1.3 Market by Application
1.3.1 Global Colorectal Cancer Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Colorectal Cancer Diagnostics Market Perspective (2016-2027)
2.2 Colorectal Cancer Diagnostics Growth Trends by Regions
2.2.1 Colorectal Cancer Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Colorectal Cancer Diagnostics Historic Market Share by Regions (2016-2021)
2.2.3 Colorectal Cancer Diagnostics Forecasted Market Size by Regions (2022-2027)
2.3 Colorectal Cancer Diagnostics Industry Dynamic
2.3.1 Colorectal Cancer Diagnostics Market Trends
2.3.2 Colorectal Cancer Diagnostics Market Drivers
2.3.3 Colorectal Cancer Diagnostics Market Challenges
2.3.4 Colorectal Cancer Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Colorectal Cancer Diagnostics Players by Revenue
3.1.1 Global Top Colorectal Cancer Diagnostics Players by Revenue (2016-2021)
3.1.2 Global Colorectal Cancer Diagnostics Revenue Market Share by Players (2016-2021)
3.2 Global Colorectal Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Colorectal Cancer Diagnostics Revenue
3.4 Global Colorectal Cancer Diagnostics Market Concentration Ratio
3.4.1 Global Colorectal Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Colorectal Cancer Diagnostics Revenue in 2020
3.5 Colorectal Cancer Diagnostics Key Players Head office and Area Served
3.6 Key Players Colorectal Cancer Diagnostics Product Solution and Service
3.7 Date of Enter into Colorectal Cancer Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Colorectal Cancer Diagnostics Breakdown Data by Type
4.1 Global Colorectal Cancer Diagnostics Historic Market Size by Type (2016-2021)
4.2 Global Colorectal Cancer Diagnostics Forecasted Market Size by Type (2022-2027)
5 Colorectal Cancer Diagnostics Breakdown Data by Application
5.1 Global Colorectal Cancer Diagnostics Historic Market Size by Application (2016-2021)
5.2 Global Colorectal Cancer Diagnostics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Colorectal Cancer Diagnostics Market Size (2016-2027)
6.2 North America Colorectal Cancer Diagnostics Market Size by Type
6.2.1 North America Colorectal Cancer Diagnostics Market Size by Type (2016-2021)
6.2.2 North America Colorectal Cancer Diagnostics Market Size by Type (2022-2027)
6.2.3 North America Colorectal Cancer Diagnostics Market Size by Type (2016-2027)
6.3 North America Colorectal Cancer Diagnostics Market Size by Application
6.3.1 North America Colorectal Cancer Diagnostics Market Size by Application (2016-2021)
6.3.2 North America Colorectal Cancer Diagnostics Market Size by Application (2022-2027)
6.3.3 North America Colorectal Cancer Diagnostics Market Size by Application (2016-2027)
6.4 North America Colorectal Cancer Diagnostics Market Size by Country
6.4.1 North America Colorectal Cancer Diagnostics Market Size by Country (2016-2021)
6.4.2 North America Colorectal Cancer Diagnostics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Colorectal Cancer Diagnostics Market Size (2016-2027)
7.2 Europe Colorectal Cancer Diagnostics Market Size by Type
7.2.1 Europe Colorectal Cancer Diagnostics Market Size by Type (2016-2021)
7.2.2 Europe Colorectal Cancer Diagnostics Market Size by Type (2022-2027)
7.2.3 Europe Colorectal Cancer Diagnostics Market Size by Type (2016-2027)
7.3 Europe Colorectal Cancer Diagnostics Market Size by Application
7.3.1 Europe Colorectal Cancer Diagnostics Market Size by Application (2016-2021)
7.3.2 Europe Colorectal Cancer Diagnostics Market Size by Application (2022-2027)
7.3.3 Europe Colorectal Cancer Diagnostics Market Size by Application (2016-2027)
7.4 Europe Colorectal Cancer Diagnostics Market Size by Country
7.4.1 Europe Colorectal Cancer Diagnostics Market Size by Country (2016-2021)
7.4.2 Europe Colorectal Cancer Diagnostics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Colorectal Cancer Diagnostics Market Size (2016-2027)
8.2 Asia-Pacific Colorectal Cancer Diagnostics Market Size by Type
8.2.1 Asia-Pacific Colorectal Cancer Diagnostics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Colorectal Cancer Diagnostics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Colorectal Cancer Diagnostics Market Size by Type (2016-2027)
8.3 Asia-Pacific Colorectal Cancer Diagnostics Market Size by Application
8.3.1 Asia-Pacific Colorectal Cancer Diagnostics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Colorectal Cancer Diagnostics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Colorectal Cancer Diagnostics Market Size by Application (2016-2027)
8.4 Asia-Pacific Colorectal Cancer Diagnostics Market Size by Region
8.4.1 Asia-Pacific Colorectal Cancer Diagnostics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Colorectal Cancer Diagnostics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Colorectal Cancer Diagnostics Market Size (2016-2027)
9.2 Latin America Colorectal Cancer Diagnostics Market Size by Type
9.2.1 Latin America Colorectal Cancer Diagnostics Market Size by Type (2016-2021)
9.2.2 Latin America Colorectal Cancer Diagnostics Market Size by Type (2022-2027)
9.2.3 Latin America Colorectal Cancer Diagnostics Market Size by Type (2016-2027)
9.3 Latin America Colorectal Cancer Diagnostics Market Size by Application
9.3.1 Latin America Colorectal Cancer Diagnostics Market Size by Application (2016-2021)
9.3.2 Latin America Colorectal Cancer Diagnostics Market Size by Application (2022-2027)
9.3.3 Latin America Colorectal Cancer Diagnostics Market Size by Application (2016-2027)
9.4 Latin America Colorectal Cancer Diagnostics Market Size by Country
9.4.1 Latin America Colorectal Cancer Diagnostics Market Size by Country (2016-2021)
9.4.2 Latin America Colorectal Cancer Diagnostics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Colorectal Cancer Diagnostics Market Size (2016-2027)
10.2 Middle East & Africa Colorectal Cancer Diagnostics Market Size by Type
10.2.1 Middle East & Africa Colorectal Cancer Diagnostics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Colorectal Cancer Diagnostics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Colorectal Cancer Diagnostics Market Size by Type (2016-2027)
10.3 Middle East & Africa Colorectal Cancer Diagnostics Market Size by Application
10.3.1 Middle East & Africa Colorectal Cancer Diagnostics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Colorectal Cancer Diagnostics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Colorectal Cancer Diagnostics Market Size by Application (2016-2027)
10.4 Middle East & Africa Colorectal Cancer Diagnostics Market Size by Country
10.4.1 Middle East & Africa Colorectal Cancer Diagnostics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Colorectal Cancer Diagnostics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Biocept
11.1.1 Biocept Company Details
11.1.2 Biocept Business Overview
11.1.3 Biocept Colorectal Cancer Diagnostics Introduction
11.1.4 Biocept Revenue in Colorectal Cancer Diagnostics Business (2016-2021)
11.1.5 Biocept Recent Development
11.2 Cancer Genetics
11.2.1 Cancer Genetics Company Details
11.2.2 Cancer Genetics Business Overview
11.2.3 Cancer Genetics Colorectal Cancer Diagnostics Introduction
11.2.4 Cancer Genetics Revenue in Colorectal Cancer Diagnostics Business (2016-2021)
11.2.5 Cancer Genetics Recent Development
11.3 Foundation Medicine
11.3.1 Foundation Medicine Company Details
11.3.2 Foundation Medicine Business Overview
11.3.3 Foundation Medicine Colorectal Cancer Diagnostics Introduction
11.3.4 Foundation Medicine Revenue in Colorectal Cancer Diagnostics Business (2016-2021)
11.3.5 Foundation Medicine Recent Development
11.4 Sysmex Corporation
11.4.1 Sysmex Corporation Company Details
11.4.2 Sysmex Corporation Business Overview
11.4.3 Sysmex Corporation Colorectal Cancer Diagnostics Introduction
11.4.4 Sysmex Corporation Revenue in Colorectal Cancer Diagnostics Business (2016-2021)
11.4.5 Sysmex Corporation Recent Development
11.5 Danaher Corporation
11.5.1 Danaher Corporation Company Details
11.5.2 Danaher Corporation Business Overview
11.5.3 Danaher Corporation Colorectal Cancer Diagnostics Introduction
11.5.4 Danaher Corporation Revenue in Colorectal Cancer Diagnostics Business (2016-2021)
11.5.5 Danaher Corporation Recent Development
11.6 Epigenomics
11.6.1 Epigenomics Company Details
11.6.2 Epigenomics Business Overview
11.6.3 Epigenomics Colorectal Cancer Diagnostics Introduction
11.6.4 Epigenomics Revenue in Colorectal Cancer Diagnostics Business (2016-2021)
11.6.5 Epigenomics Recent Development
11.7 Illumina
11.7.1 Illumina Company Details
11.7.2 Illumina Business Overview
11.7.3 Illumina Colorectal Cancer Diagnostics Introduction
11.7.4 Illumina Revenue in Colorectal Cancer Diagnostics Business (2016-2021)
11.7.5 Illumina Recent Development
11.8 Rosetta Genomics
11.8.1 Rosetta Genomics Company Details
11.8.2 Rosetta Genomics Business Overview
11.8.3 Rosetta Genomics Colorectal Cancer Diagnostics Introduction
11.8.4 Rosetta Genomics Revenue in Colorectal Cancer Diagnostics Business (2016-2021)
11.8.5 Rosetta Genomics Recent Development
11.9 Exact Science Corporation
11.9.1 Exact Science Corporation Company Details
11.9.2 Exact Science Corporation Business Overview
11.9.3 Exact Science Corporation Colorectal Cancer Diagnostics Introduction
11.9.4 Exact Science Corporation Revenue in Colorectal Cancer Diagnostics Business (2016-2021)
11.9.5 Exact Science Corporation Recent Development
11.10 Pathway Genomics Corporation
11.10.1 Pathway Genomics Corporation Company Details
11.10.2 Pathway Genomics Corporation Business Overview
11.10.3 Pathway Genomics Corporation Colorectal Cancer Diagnostics Introduction
11.10.4 Pathway Genomics Corporation Revenue in Colorectal Cancer Diagnostics Business (2016-2021)
11.10.5 Pathway Genomics Corporation Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Colorectal Cancer Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of FOB Tests
Table 3. Key Players of CTC Tests
Table 4. Key Players of CEA Tests
Table 5. Key Players of Others
Table 6. Global Colorectal Cancer Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Colorectal Cancer Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Colorectal Cancer Diagnostics Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Colorectal Cancer Diagnostics Market Share by Regions (2016-2021)
Table 10. Global Colorectal Cancer Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Colorectal Cancer Diagnostics Market Share by Regions (2022-2027)
Table 12. Colorectal Cancer Diagnostics Market Trends
Table 13. Colorectal Cancer Diagnostics Market Drivers
Table 14. Colorectal Cancer Diagnostics Market Challenges
Table 15. Colorectal Cancer Diagnostics Market Restraints
Table 16. Global Colorectal Cancer Diagnostics Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Colorectal Cancer Diagnostics Market Share by Players (2016-2021)
Table 18. Global Top Colorectal Cancer Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Colorectal Cancer Diagnostics as of 2020)
Table 19. Ranking of Global Top Colorectal Cancer Diagnostics Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Colorectal Cancer Diagnostics Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Colorectal Cancer Diagnostics Product Solution and Service
Table 23. Date of Enter into Colorectal Cancer Diagnostics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Colorectal Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Colorectal Cancer Diagnostics Revenue Market Share by Type (2016-2021)
Table 27. Global Colorectal Cancer Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Colorectal Cancer Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Colorectal Cancer Diagnostics Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Colorectal Cancer Diagnostics Revenue Market Share by Application (2016-2021)
Table 31. Global Colorectal Cancer Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Colorectal Cancer Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Colorectal Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Colorectal Cancer Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Colorectal Cancer Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Colorectal Cancer Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Colorectal Cancer Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Colorectal Cancer Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Colorectal Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Colorectal Cancer Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Colorectal Cancer Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Colorectal Cancer Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Colorectal Cancer Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Colorectal Cancer Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Colorectal Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Colorectal Cancer Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Colorectal Cancer Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Colorectal Cancer Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Colorectal Cancer Diagnostics Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Colorectal Cancer Diagnostics Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Colorectal Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Colorectal Cancer Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Colorectal Cancer Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Colorectal Cancer Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Colorectal Cancer Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Colorectal Cancer Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Colorectal Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Colorectal Cancer Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Colorectal Cancer Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Colorectal Cancer Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Colorectal Cancer Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Colorectal Cancer Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 63. Biocept Company Details
Table 64. Biocept Business Overview
Table 65. Biocept Colorectal Cancer Diagnostics Product
Table 66. Biocept Revenue in Colorectal Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 67. Biocept Recent Development
Table 68. Cancer Genetics Company Details
Table 69. Cancer Genetics Business Overview
Table 70. Cancer Genetics Colorectal Cancer Diagnostics Product
Table 71. Cancer Genetics Revenue in Colorectal Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 72. Cancer Genetics Recent Development
Table 73. Foundation Medicine Company Details
Table 74. Foundation Medicine Business Overview
Table 75. Foundation Medicine Colorectal Cancer Diagnostics Product
Table 76. Foundation Medicine Revenue in Colorectal Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 77. Foundation Medicine Recent Development
Table 78. Sysmex Corporation Company Details
Table 79. Sysmex Corporation Business Overview
Table 80. Sysmex Corporation Colorectal Cancer Diagnostics Product
Table 81. Sysmex Corporation Revenue in Colorectal Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 82. Sysmex Corporation Recent Development
Table 83. Danaher Corporation Company Details
Table 84. Danaher Corporation Business Overview
Table 85. Danaher Corporation Colorectal Cancer Diagnostics Product
Table 86. Danaher Corporation Revenue in Colorectal Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 87. Danaher Corporation Recent Development
Table 88. Epigenomics Company Details
Table 89. Epigenomics Business Overview
Table 90. Epigenomics Colorectal Cancer Diagnostics Product
Table 91. Epigenomics Revenue in Colorectal Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 92. Epigenomics Recent Development
Table 93. Illumina Company Details
Table 94. Illumina Business Overview
Table 95. Illumina Colorectal Cancer Diagnostics Product
Table 96. Illumina Revenue in Colorectal Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 97. Illumina Recent Development
Table 98. Rosetta Genomics Company Details
Table 99. Rosetta Genomics Business Overview
Table 100. Rosetta Genomics Revenue in Colorectal Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 101. Rosetta Genomics Recent Development
Table 102. Exact Science Corporation Company Details
Table 103. Exact Science Corporation Business Overview
Table 104. Exact Science Corporation Colorectal Cancer Diagnostics Product
Table 105. Exact Science Corporation Revenue in Colorectal Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 106. Exact Science Corporation Recent Development
Table 107. Pathway Genomics Corporation Company Details
Table 108. Pathway Genomics Corporation Business Overview
Table 109. Pathway Genomics Corporation Colorectal Cancer Diagnostics Product
Table 110. Pathway Genomics Corporation Revenue in Colorectal Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 111. Pathway Genomics Corporation Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Colorectal Cancer Diagnostics Market Share by Type: 2020 VS 2027
Figure 2. FOB Tests Features
Figure 3. CTC Tests Features
Figure 4. CEA Tests Features
Figure 5. Others Features
Figure 6. Global Colorectal Cancer Diagnostics Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Specialty Clinics Case Studies
Figure 9. Others Case Studies
Figure 10. Colorectal Cancer Diagnostics Report Years Considered
Figure 11. Global Colorectal Cancer Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Colorectal Cancer Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Colorectal Cancer Diagnostics Market Share by Regions: 2020 VS 2027
Figure 14. Global Colorectal Cancer Diagnostics Market Share by Regions (2022-2027)
Figure 15. Global Colorectal Cancer Diagnostics Market Share by Players in 2020
Figure 16. Global Top Colorectal Cancer Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Colorectal Cancer Diagnostics as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Colorectal Cancer Diagnostics Revenue in 2020
Figure 18. Global Colorectal Cancer Diagnostics Revenue Market Share by Type (2016-2021)
Figure 19. Global Colorectal Cancer Diagnostics Revenue Market Share by Type (2022-2027)
Figure 20. North America Colorectal Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Colorectal Cancer Diagnostics Market Share by Type (2016-2027)
Figure 22. North America Colorectal Cancer Diagnostics Market Share by Application (2016-2027)
Figure 23. North America Colorectal Cancer Diagnostics Market Share by Country (2016-2027)
Figure 24. United States Colorectal Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Colorectal Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Colorectal Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Colorectal Cancer Diagnostics Market Share by Type (2016-2027)
Figure 28. Europe Colorectal Cancer Diagnostics Market Share by Application (2016-2027)
Figure 29. Europe Colorectal Cancer Diagnostics Market Share by Country (2016-2027)
Figure 30. Germany Colorectal Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Colorectal Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Colorectal Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Colorectal Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Colorectal Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Colorectal Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Colorectal Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Colorectal Cancer Diagnostics Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Colorectal Cancer Diagnostics Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Colorectal Cancer Diagnostics Market Share by Region (2016-2027)
Figure 40. China Colorectal Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Colorectal Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Colorectal Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Colorectal Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Colorectal Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Colorectal Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Colorectal Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Colorectal Cancer Diagnostics Market Share by Type (2016-2027)
Figure 48. Latin America Colorectal Cancer Diagnostics Market Share by Application (2016-2027)
Figure 49. Latin America Colorectal Cancer Diagnostics Market Share by Country (2016-2027)
Figure 50. Mexico Colorectal Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Colorectal Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Colorectal Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Colorectal Cancer Diagnostics Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Colorectal Cancer Diagnostics Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Colorectal Cancer Diagnostics Market Share by Country (2016-2027)
Figure 56. Turkey Colorectal Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Colorectal Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Colorectal Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Biocept Revenue Growth Rate in Colorectal Cancer Diagnostics Business (2016-2021)
Figure 60. Cancer Genetics Revenue Growth Rate in Colorectal Cancer Diagnostics Business (2016-2021)
Figure 61. Foundation Medicine Revenue Growth Rate in Colorectal Cancer Diagnostics Business (2016-2021)
Figure 62. Sysmex Corporation Revenue Growth Rate in Colorectal Cancer Diagnostics Business (2016-2021)
Figure 63. Danaher Corporation Revenue Growth Rate in Colorectal Cancer Diagnostics Business (2016-2021)
Figure 64. Epigenomics Revenue Growth Rate in Colorectal Cancer Diagnostics Business (2016-2021)
Figure 65. Illumina Revenue Growth Rate in Colorectal Cancer Diagnostics Business (2016-2021)
Figure 66. Rosetta Genomics Revenue Growth Rate in Colorectal Cancer Diagnostics Business (2016-2021)
Figure 67. Exact Science Corporation Revenue Growth Rate in Colorectal Cancer Diagnostics Business (2016-2021)
Figure 68. Pathway Genomics Corporation Revenue Growth Rate in Colorectal Cancer Diagnostics Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
世界の結腸直腸がんスクリーニング市場規模・現状・予測（2021年-2027年） Colorectal cancer (CRC) is known as bowel cancer and colon cancer. It is the development of cancer from the colon or rectum. Screening for colorectal cancer can help prevent and treat the disease. Market Analysis and Insights: Global Colorectal Cancer Screening Market The global Colorectal Cancer Sc…- 世界の遺伝性大腸がん分子診断市場規模・現状・予測（2021年-2027年） A method for diagnosing hereditary colorectal cancer Market Analysis and Insights: Global Molecular Diagnosis of Hereditary Colorectal Cancer Market The global Molecular Diagnosis of Hereditary Colorectal Cancer market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, a…
- 世界の転移性結腸直腸癌治療市場規模・現状・予測（2021年-2027年） Colorectal cancer is the third most common type cancer and represents 9.7% of total cancer cases across the globe. According to American Cancer Society colorectal cancer is treatable and curable when it is localized to the bowel. However, colorectal cancer cancers that have spread to other body part…
- 世界の結腸直腸癌治療市場規模・現状・予測（2021年-2027年） Colorectal cancer therapeutics market trends, there are a number of factors providing major impetus to the growth of these drugs. Market Analysis and Insights: Global Colorectal Cancer Treatment Market The global Colorectal Cancer Treatment market size is projected to reach US$ XX million by 2027, f…
- 大腸がんのスクリーニングのグローバル市場：規模・現状・予測2019-2025 Colorectal cancer (CRC) is known as bowel cancer and colon cancer. It is the development of cancer from the colon or rectum. Screening for colorectal cancer can help prevent and treat the disease.In 2018, the global Colorectal Cancer Screening market size was xx million US$ and it is expected to rea…